LINCTOBC Trademark

Trademark Overview


On Wednesday, November 17, 2021, a trademark application was filed for LINCTOBC with the United States Patent and Trademark Office. The USPTO has given the LINCTOBC trademark a serial number of 79332438. The federal status of this trademark filing is REGISTERED as of Tuesday, November 21, 2023. This trademark is owned by INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM). The LINCTOBC trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific and research apparatus and instruments in the field of health, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor, prisms for scientific and medical research purposes; Recorded software for diagnosing the risk of developing breast cancer; Downloadable computer application software for mobile phones and handheld computers for diagnosing the risk of developing breast cancer; Downloadable computer software for diagnosing the risk of developing breast cancer and downloadable computer application software for mobile devices for diagnosing the risk of developing breast cancer; Downloadable computer software platforms for diagnosing the risk of developing breast cancer and downloadable mobile application software for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy

Health services, namely, oncologic health care; Medical services; Therapeutic services, namely, radiotherapeutic agent therapy, immunotherapeutic agent therapy, chemotherapeutic agent therapy services and surgery; Medical assistance; Medical clinic services and medical analysis services provided by medical laboratories for diagnostic and therapeutic treatment purposes; Advice regarding health; Telemedicine services; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy

Scientific research services for medical purposes in the field of breast cancer therapy; Medical research; Design, development, maintenance and updating of computer software; Development of computer platforms; Computer system design; Computer programming; Electronic data storage; Computer software consultancy; Software as a service (SaaS) services featuring software for diagnosing the risk of developing breast cancer; Platform as a service (PaaS) featuring computer software platforms for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy
linctobc

General Information


Serial Number79332438
Word MarkLINCTOBC
Filing DateWednesday, November 17, 2021
Status700 - REGISTERED
Status DateTuesday, November 21, 2023
Registration Number7220365
Registration DateTuesday, November 21, 2023
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 5, 2023

Trademark Statements


Goods and ServicesScientific and research apparatus and instruments in the field of health, namely, scientific apparatus and instruments for measuring relative DNA, RNA and protein and parts and fittings therefor, prisms for scientific and medical research purposes; Recorded software for diagnosing the risk of developing breast cancer; Downloadable computer application software for mobile phones and handheld computers for diagnosing the risk of developing breast cancer; Downloadable computer software for diagnosing the risk of developing breast cancer and downloadable computer application software for mobile devices for diagnosing the risk of developing breast cancer; Downloadable computer software platforms for diagnosing the risk of developing breast cancer and downloadable mobile application software for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy
Pseudo MarkLINC TO BC; LINK TO BC; LINC TO BREAST CANCER; LINK TO BREAST CANCER
Goods and ServicesHealth services, namely, oncologic health care; Medical services; Therapeutic services, namely, radiotherapeutic agent therapy, immunotherapeutic agent therapy, chemotherapeutic agent therapy services and surgery; Medical assistance; Medical clinic services and medical analysis services provided by medical laboratories for diagnostic and therapeutic treatment purposes; Advice regarding health; Telemedicine services; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy
Goods and ServicesScientific research services for medical purposes in the field of breast cancer therapy; Medical research; Design, development, maintenance and updating of computer software; Development of computer platforms; Computer system design; Computer programming; Electronic data storage; Computer software consultancy; Software as a service (SaaS) services featuring software for diagnosing the risk of developing breast cancer; Platform as a service (PaaS) featuring computer software platforms for diagnosing the risk of developing breast cancer; All of the aforesaid goods dedicated to the diagnosis, prognosis and management of breast cancer therapy

Classification Information


International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status Code6 - Active
Class Status DateFriday, February 4, 2022
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 4, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, February 4, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR

Party NameINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR

Party NameINSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events


Event DateEvent Description
Thursday, February 3, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, February 4, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 8, 2022APPLICATION FILING RECEIPT MAILED
Monday, August 22, 2022ASSIGNED TO EXAMINER
Friday, August 26, 2022NON-FINAL ACTION WRITTEN
Saturday, August 27, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Thursday, October 20, 2022REFUSAL PROCESSED BY MPU
Thursday, October 20, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 8, 2022REFUSAL PROCESSED BY IB
Thursday, March 30, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, March 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, March 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, April 19, 2023FINAL REFUSAL WRITTEN
Wednesday, April 19, 2023FINAL REFUSAL E-MAILED
Wednesday, April 19, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Monday, June 26, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Monday, June 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, July 5, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, July 25, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, August 1, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 16, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 16, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 16, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Monday, September 4, 2023NOTIFICATION PROCESSED BY IB
Tuesday, September 5, 2023PUBLISHED FOR OPPOSITION
Tuesday, September 5, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 21, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, November 21, 2023REGISTERED-PRINCIPAL REGISTER
Wednesday, February 21, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, February 22, 2024GENERIC MADRID TRANSACTION CREATED
Thursday, February 22, 2024GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, March 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 22, 2024NEW REPRESENTATIVE AT IB RECEIVED